Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | VRTX | REGN | BMY |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 146.07 | 276.11 | 396.20 | 892.11 | 44.40 |
| High | 148.05 | 276.12 | 396.69 | 896.85 | 44.76 |
| Low | 145.17 | 272.35 | 392.50 | 885.01 | 43.97 |
| Last | 145.31 | 274.11 | 394.15 | 890.88 | 44.34 |
| Change | -2.05 | -2.27 | -2.05 | -1.60 | -0.30 |
| % Change | -1.39% | -0.82% | -0.52% | -0.18% | -0.67% |
| Volume | 200,246 | 900,022 | 565,660 | 299,308 | 8,723,862 |
| 20-Day Average Volume | 474,942 | 2,127,817 | 913,569 | 449,987 | 13,440,406 |
| Previous Close | 147.36 | 276.38 | 396.20 | 892.48 | 44.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 148.29 | 269.56 | 399.28 | 911.61 | 48.64 |
| 20-Day Raw Stochastic | 20.64% | 84.92% | 11.35% | 20.31% | 5.39% |
| 20-Day Relative Strength | 42.62% | 50.05% | 39.87% | 37.65% | 28.20% |
| Weighted Alpha | -31.52 | +12.89 | +11.46 | +15.27 | -35.74 |
| Today's Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 88% Sell | 24% Buy | 56% Buy | 96% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.35% since 04/23/24 | +0.32% since 04/23/24 | -2.76% since 04/23/24 | -1.59% since 04/23/24 | -9.27% since 04/23/24 |
| Low | 141.98 on 04/25/24 | 265.72 on 04/26/24 | 392.50 on 04/30/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 148.49 on 04/29/24 | 276.86 on 04/29/24 | 406.83 on 04/24/24 | 915.70 on 04/24/24 | 49.04 on 04/24/24 |
| 1-Month | |||||
| %Chg | -2.60% since 03/28/24 | -3.48% since 03/28/24 | -5.81% since 03/28/24 | -7.23% since 03/28/24 | -18.03% since 03/28/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 159.34 on 04/09/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | -19.19% since 01/30/24 | -12.78% since 01/30/24 | -11.74% since 01/30/24 | -6.96% since 01/30/24 | -10.00% since 01/30/24 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 179.80 on 01/31/24 | 329.72 on 02/05/24 | 444.07 on 01/31/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -3.86% since 10/30/23 | +4.27% since 10/30/23 | +10.15% since 10/30/23 | +14.82% since 10/30/23 | -13.27% since 10/30/23 |
| Low | 141.98 on 04/25/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 43.97 on 04/30/24 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,559,402 | 148,243,600 | 102,401,456 | 97,960,392 | 90,489,744 |
| Shares Outstanding, K | 125,946 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 439,720,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -137,870,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.39 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/15/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 29.57 | 23.50 | 42.71 |